| BCOR involvement in cancer A Astolfi, M Fiore, F Melchionda, V Indio, SN Bertuccio, A Pession Epigenomics 11 (7), 835-855, 2019 | 128 | 2019 |
| CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity R Masetti, SN Bertuccio, A Pession, F Locatelli British journal of haematology 184 (3), 337-347, 2019 | 51 | 2019 |
| Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene R Masetti, SN Bertuccio, A Astolfi, F Chiarini, A Lonetti, V Indio, M De Luca, ... Journal of hematology & oncology 10, 1-5, 2017 | 41 | 2017 |
| Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase SN Bertuccio, S Serravalle, A Astolfi, A Lonetti, V Indio, A Leszl, A Pession, ... Oncotarget 8 (66), 109915, 2017 | 35 | 2017 |
| Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing R Masetti, I Castelli, A Astolfi, SN Bertuccio, V Indio, M Togni, T Belotti, ... Oncotarget 7 (35), 56746, 2016 | 34 | 2016 |
| Necrotizing enterocolitis: overview on in vitro models L De Fazio, I Beghetti, SN Bertuccio, C Marsico, S Martini, R Masetti, ... International Journal of Molecular Sciences 22 (13), 6761, 2021 | 23 | 2021 |
| Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for … A Lonetti, V Indio, MA Laginestra, G Tarantino, F Chiarini, A Astolfi, ... Cancers 12 (7), 1972, 2020 | 23 | 2020 |
| Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion A Astolfi, R Masetti, V Indio, SN Bertuccio, D Messelodi, S Rampelli, ... Blood, The Journal of the American Society of Hematology 138 (18), 1773-1777, 2021 | 21 | 2021 |
| Role of CBL mutations in cancer and non-malignant phenotype D Leardini, D Messelodi, E Muratore, F Baccelli, SN Bertuccio, L Anselmi, ... Cancers 14 (3), 839, 2022 | 18 | 2022 |
| Synergistic cytotoxic effect of l‐asparaginase combined with decitabine as a demethylating agent in pediatric T‐ALL, with specific epigenetic signature S Serravalle, SN Bertuccio, A Astolfi, F Melchionda, A Pession BioMed Research International 2016 (1), 1985750, 2016 | 14 | 2016 |
| The Pediatric Acute Leukemia Fusion Oncogene ETO2‐GLIS2 Increases Self‐Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells‐Derived Model SN Bertuccio, F Boudia, M Cambot, CK Lopez, L Lordier, A Donada, ... HemaSphere 4 (1), e319, 2020 | 11 | 2020 |
| Insights on the interplay between cells metabolism and signaling: A therapeutic perspective in pediatric acute leukemias L Anselmi, SN Bertuccio, A Lonetti, A Prete, R Masetti, A Pession International Journal of Molecular Sciences 21 (17), 6251, 2020 | 8 | 2020 |
| Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities A Pession, A Lonetti, S Bertuccio, F Locatelli, R Masetti Expert Opinion on Therapeutic Targets 23 (2), 87-91, 2019 | 8 | 2019 |
| BCOR involvement in cancer. Epigenomics 11: 835–855 A Astolfi, M Fiore, F Melchionda, V Indio, SN Bertuccio, A Pession | 8 | 2019 |
| iPSC-Derived gaucher macrophages display growth impairment and activation of inflammation-related cell death D Messelodi, SN Bertuccio, V Indio, S Strocchi, A Taddia, S Serravalle, ... Cells 10 (11), 2822, 2021 | 7 | 2021 |
| Exploiting clonal evolution to improve the diagnosis and treatment efficacy prediction in pediatric AML SN Bertuccio, L Anselmi, R Masetti, A Lonetti, S Cerasi, S Polidori, ... Cancers 13 (9), 1995, 2021 | 7 | 2021 |
| ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution F Baccelli, D Leardini, S Cerasi, D Messelodi, SN Bertuccio, R Masetti Annals of Hematology 102 (4), 699-705, 2023 | 5 | 2023 |
| Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity S De Matteis, M Dicataldo, B Casadei, G Storci, N Laprovitera, M Arpinati, ... Frontiers in Immunology 13, 1058126, 2023 | 5 | 2023 |
| Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children R Masetti, SN Bertuccio, V Guidi, S Cerasi, A Lonetti, A Pession Future Oncology 16 (33), 2747-2762, 2020 | 5 | 2020 |
| Successful treatment of a chemotherapy-resistant t (17; 19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax F Gottardi, F Baccelli, D Leardini, A Di Battista, P Castellucci, D D'Amico, ... British journal of haematology 202 (5), e39-e42, 2023 | 3 | 2023 |
